CD38 and Parkinson disease: Based upon the established relationship of inflammation to PD development, one may suspect that reduced astrocytic inflammatory profiles by CD38 loss may be beneficial; however, this concept is not corroborated by human data (Ge et al. 2023; Yao et al. 2021; Zhou et al. 2023).